BERLIN (Reuters) – Roche is actively working to enhance laboratory testing capacity for mpox worldwide, the Swiss pharmaceutical company said on Tuesday.
The World Health Organization last week declared mpox a global public health emergency for the second time in two years as a new variant of the disease, known as clade 1b, spread rapidly in Africa.
Roche said it is partnering with governments, healthcare providers and organizations to combat the outbreak, as well as providing training for labs across the African continent.
(Writing by Miranda Murray, Editing by Rachel More)
Comments